Trials / Completed
CompletedNCT00618332
Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?
Does the Response to a Nasal Decongestant Test Predict the Outcome to Treatment of Seasonal Allergic Rhinitis With Nasonex?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesize that those patients with purely seasonal allergic rhinitis will decongest better than those subjects with another cause contributing to their symptoms. These latter patients will not improve as well on an intranasal steroid as those who decongest well, potentially explaining the 60% response rate in prior studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mometasone furoate nasal spray | 2 puffs in each nostril once a day for 2 weeks |
| DRUG | placebo | 2 puffs in each nostril once a day for 2 weeks |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-07-01
- Completion
- 2010-07-01
- First posted
- 2008-02-20
- Last updated
- 2014-02-14
- Results posted
- 2014-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00618332. Inclusion in this directory is not an endorsement.